Delivery Order HHSN272201500006I-75N93021F00001
Award Date
12/15/20
Potential Completion Date
12/14/21
Potential Value
$110K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Duke University, a private university and non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, with a ceiling value of $212,814.70....
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,281,164 cost-no-fee delivery order to Duke University's Office of Research Administration Division to conduct a Phase 1 clinical trial on therapeutics against infectious diseases. The order is part of a larger Therapeutics Against Infectious Diseases Phase 1 contract. No set-aside designation was used. Duke University is a private research university...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The contract is for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases and has a ceiling value of $127,244.88. It is a delivery order awarded under the Therapeutics Against Infectious Diseases Phase 1 contract vehicle. The contract does not have a set-aside designation. Duke University, a private non-profit educational...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $136,864.00 delivery order contract to Duke University for Phase 1 clinical trial unit services to support Therapeutics Against Infectious Diseases research. The contract is not set aside and is part of a master Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on therapeutics against infectious diseases. As the prime contractor, Duke...
This is a cost-no-fee Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a ceiling value of $416,539.69 and a period of performance through August 31, 2017. This order is part of a larger Therapeutics Against Infectious Diseases Phase 1 Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. No set-aside...
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The potential value of the award is $126,086.19. The order was issued against the Therapeutics Against Infectious Diseases Phase 1 master contract. No set-aside designation was used. As the prime contractor, Duke University will provide clinical...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $138,686 delivery order to Duke University's Office of Research Administration Division for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a potential value of $115,875.31 and a completion date of December 14, 2018. This delivery order is part of a larger Therapeutics Against Infectious Diseases Phase 1 indefinite...
This federal contract award is for a Phase 1 clinical trial protocol development, implementation, and research laboratory analysis task for a therapeutic against malaria. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University for $40,257. This task is part of the Therapeutics Against Infectious Diseases Phase 1 contract vehicle, which is a larger program supporting the development of therapeutics against infectious...
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The task order is under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award is for $1,963,927.00 and does not have a set-aside designation. The contract is for a cost-no-fee delivery order, with a period of performance extending to January 13, 2032. Duke University, a private...
This federal contract award to Duke University was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $13,368,236.91 definitive contract is for an "IMMUNOLOGY QUALITY ASSESSMENT PROGRAM" and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the contract has a period of performance ending on September...